AstraZeneca awards $3.4 million for programs to improve access to healthcare for patients across the USBusiness Wire • 02/11/26
AZN Q4 Earnings Miss Estimates, Stock Up on Robust 2026 Growth OutlookZacks Investment Research • 02/10/26
Here's What Key Metrics Tell Us About Astrazeneca (AZN) Q4 EarningsZacks Investment Research • 02/10/26
AstraZeneca Leans On Its Cancer Division For A Fourth-Quarter BeatInvestors Business Daily • 02/10/26
AstraZeneca lifts earnings as pipeline delivery and global expansion underpin growthProactive Investors • 02/10/26
Countdown to Astrazeneca (AZN) Q4 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 02/05/26
AstraZeneca to Report Q4 Earnings: What's in Store for the Stock?Zacks Investment Research • 02/05/26
FDA Rejects AZN's Saphnelo SubQ Formulation, Priority Tag to DatrowayZacks Investment Research • 02/04/26
AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovationCNBC • 02/01/26